AXIM Axim Biotechnologies Inc (QB)

0.00 (0.0%)
Sep 29 2023 - Closed
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.


Draw Mode:

Volume 0.00
Bid Price 0.0215
Ask Price 0.0252
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
Axim Biotechnologies Inc (QB) AXIM OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.0215 07:01:54
Open Price Low Price High Price Close Price Prev Close
Trades Volume Avg Volume 52 Week Range
0 0.00 - 0.0159 - 0.118
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.0215 USD

Axim Biotechnologies Inc (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
4.89M 227.65M 39.53M 9k -6.24M -0.03 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Axim Biotechnologies (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No AXIM Message Board. Create One! See More Posts on AXIM Message Board See More Message Board Posts

Historical AXIM Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.02860.02990.020.0227427398,752-0.0071-24.83%
1 Month0.02260.03290.01880.0244896402,266-0.0011-4.87%
3 Months0.03590.0360.01880.0265035350,769-0.0144-40.11%
6 Months0.03140.0550.01630.0270468311,715-0.0099-31.53%
1 Year0.093050.1180.01590.0310758357,422-0.07155-76.89%
3 Years0.661.220.01590.2140945298,760-0.6385-96.74%
5 Years1.912.500.01590.409609277,426-1.89-98.87%

Axim Biotechnologies (QB) Description

Axim Biotechnologies, Inc. is a leading developer of diagnostic healthcare solutions serving to enhance the health of people. Through the development of diagnostic solutions that quickly and accurately diagnose various diseases, our products allow healthcare workers to quickly test and treat at the point-of-care, which leads to improved patient outcomes and provides numerous economic benefits to the healthcare system. Axim's core competencies include development of rapid lateral flow immunoassays, reagents and monoclonal antibody development for such assays.